• Profile
Close

Long-term clinical and cost-effectiveness of early endovenous ablation in venous ulceration

JAMA Sep 30, 2020

Gohel MS, Mora J, Szigeti M, et al. - Researchers sought to evaluate the clinical and cost-effectiveness of early endovenous ablation of superficial venous reflux in patients with venous leg ulceration.  They performed a multicenter, randomized clinical trial including 450-patient with venous leg ulceration of less than 6 months’ duration and superficial venous reflux. Participants underwent randomization to receive either compression therapy with early endovenous ablation within 2 weeks of randomization (early intervention, n = 224) or compression with deferred endovenous treatment of superficial venous reflux (deferred intervention, n = 226). Accelerated venous ulcer healing was observed in correlation with undergoing early endovenous ablation with compression. Further, it was associated with reduced overall incidence of ulcer recurrence, and was highly cost-effective compared with compression with deferred intervention. In view of findings, they emphasize revising leg ulcer care pathways to include early assessment and treatment of superficial venous reflux to attain clinical and cost benefits.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay